Does behavioural toxicity of SSRI increased risk for school shootings?;Verhaltensaktivierung durch SSRI als gefahr für amoktaten von jugendlichen?

Nervenheilkunde

Volumn 29, Issue 7-8, 2010, Pages 451-455

  Kölch, Michael ^a   Plener, P ^a   Allroggen, M ^a   Fegert, J M ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Antidepressants; Behavioural toxicity; School shootings; SSRI

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; AGGRESSION; ARTICLE; CHILD; DEPRESSION; HUMAN; IMPULSIVENESS; NEUROBIOLOGY; SCHOOL; SCHOOL SHOOTING; SEROTONINERGIC SYSTEM; SUICIDE; SYSTEMATIC REVIEW; VIOLENCE;

EID: 77956214098     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1628798     Document Type: Article

References (54)

1. Preti A, Cascio MT. Prison suicides and self-harming behaviours in Italy, 1990-2002. Med Sci Law 2006; 46(2): 127-34.
2. Twemlow SW et al. Premeditated mass shootings in schools: threat assessment. J Am Acad Child Adolesc Psychiatry 2002; 41(4): 475-7.
3. Freud S. Das Ich und das Es. Studienausgabe Bd. III 1975; 4.
4. Petermann F, Döpfner M, Schmidt M. Aggressiv - dissoziale Störungen. Göttingen: Hogrefe Verlag 2001.
5. Center for Disease Control. Suicide attempts and physical fighting among High School students. MMWR, Morbidity and Morality Weekly Report 2004; 53(22): 474-6.
6. Reuter-Rice K. Male adolescent bullying and the school shooter. J Sch Nurs 2008; 24(6): 350-9.
7. Marohn RC. Management of the assaultive adolescent. Hosp Community Psychiatry 1992; 43(6): 622-4.
8. Ilomaki E, Rasanen P, Viilo K, Hakko H. Suicidal behavior among adolescents with conduct disorder - the role of alcohol dependence. Psychiatry Res 2007; 150(3): 305-11. (Pubitemid 46466958)
9. Harrington R. Depression, suicide and deliberate self-harm in adolescence. Br Med Bull 2001; 57: 47-60. (Pubitemid 32612670)
10. American College of Neuropsychopharmacology. Executive summary preliminary report of the tast force on SSRI and suicidal behavior in youth. January 21, 2004.
11. Nelson LS et al. Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 2007; 45(4): 315-32.
12. Statistisches Bundesamt. Statistisches Jahrbuch Wiesbaden 2007.
13. Salvatore S. Columbine shooter was prescribed anti-depressant. CNN interactive 1999; 20.04.2010; http://edition.cnn.com/HEALTH/9904/29/luvox. explainer.
14. Kölch M, Fegert J. Medikamentöse Therapie der Depression bei Kindern und Jugendlichen. Praxis der Kinderpsychologie und Kinderpsychiatrie 2007; 56(3): 224-33.
15. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006; 63(3): 332-9. (Pubitemid 43345358)
16. Goodman WK, Murphy TK, Storch EA. Risk of adverse behavioral effects with pediatric use of antidepressants. Psychopharmacology (Berl) 2007; 191(1): 87-96.
17. Murphy TK, Segarra A, Storch EA, Goodman WK. SSRI adverse events: how to monitor and manage. Int Rev Psychiatry 2008; 20(2): 203-8. (Pubitemid 351489519)
18. Singh T, Prakash A, Rais T, Kumari N. Decreased use of antidepressants in youth after US Food and Drug Administration black box warning. Psychiatry (Edgmont) 2009; 6(10): 30-4.
19. Exeter D, Robinson E, Wheeler A. Antidepressant dispensing trends in New Zealand between 2004 and 2007. Aust NZJ Psychiatry 2009; 43(12): 1131-40.
20. Fergusson D et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. Bmj 2005; 330(7488): 396. (Pubitemid 40288826)
21. Mosholder AD, Willy M. Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: a meta-analysis. J Child Adolesc Psychopharmacol 2006; 16(1-2): 25-32.
22. Mosholder AD, Pamer CA. Postmarketing surveillance of suicidal adverse events with pediatric use of antidepressants. J Child Adolesc Psychopharmacol 2006; 16(1-2): 33-6.
23. Safer DJ, Zito JM. Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents. J Child Adolesc Psychopharmacol 2006; 16(1-2): 159-69.
24. Dubicka B, Hadley S, Roberts C. Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis. Br J Psychiatry 2006; 189: 393-8. (Pubitemid 44683169)
25. Bridge JA et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. Jama 2007; 297(15): 1683-96.
26. European Medicines Agency. Announcement of European Medicines Agency priorities for adverse drug reaction research 2009.
27. Henry C, Demotes-Mainard J. SSRIs, suicide and violent behavior: is there a need for a better definition of the depressive state? Curr Drug Saf 2006; 1(1): 59-62.
28. Walsh MT, Dinan TG. Selective serotonin reuptake inhibitors and violence: a review of the available evidence. Acta Psychiatr Scand 2001; 104(2): 84-91. (Pubitemid 32656082)
29. Audenaert K et al. Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate selfharm patients. Eur J Nucl Med 2001; 28(2): 175-82. (Pubitemid 32186632)
30. Audenaert K, Peremans K, Goethals I, van Heeringen C. Functional imaging, serotonin and the suicidal brain. Acta Neurol Belg 2006; 106(3): 125-31. (Pubitemid 44613872)
31. Asberg M, Traskman L, Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 1976; 33(10): 1193-7.
32. Fazel S, Grann M, Ahlner J, Goodwin G. Suicides by violent means in individuals taking SSRIs and other antidepressants: a postmortem study in Sweden, 1992-2004. J Clin Psychopharmacol 2007; 27(5): 503-6.
33. Carlin NP, Jr., Hardisty R. SSRI-induced violent suicide: does forensic toxicology hold the answer? J Clin Psychopharmacol 2008; 28(4): 476-7.
34. Henriksson S, Boethius G, Isacsson G. Suicides are seldom prescribed antidepressants: findings from a prospective prescription database in Jamtland county, Sweden, 1985-95. Acta Psychiatr Scand 2001; 103(4): 301-6.
35. Isacsson G, Holmgren P, Druid H, Bergman U. The utilization of antidepressants - a key issue in the prevention of suicide: an analysis of 5281 suicides in Sweden during the period 1992-1994. Acta Psychiatr Scand 1997; 96(2): 94-100.
36. Gray D et al. Utah youth suicide study, phase I: government agency contact before death. J Am Acad Child Adolesc Psychiatry 2002; 41(4): 427-34. (Pubitemid 38327919)
37. Gray D, Moskos M, Keller T. Utah youth suicide study new findings. In: Annual meeting of the American Association of Suicidology; Sante Fe, New Mexico 2003.
38. Kessler RC et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62(6): 593-602. (Pubitemid 40973434)
39. Kessler RC et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62(6): 617-27.
40. Birmaher B et al. Childhood and adolescent depression: a review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry 1996; 35(11): 1427-39. (Pubitemid 26360928)
41. Lewinsohn PM, Rohde P, Seeley JR. Psychosocial risk factors for future adolescent suicide attempts. J Consult Clin Psychol 1994; 62(2): 297-305. (Pubitemid 24129508)
42. Essau CA, Petermann F, Conradt J. Depressive Symptome und Syndrome bei Jugendlichen. Z Klin Psychol Psychiatr Psychother 1996; 44(2): 150-7.
43. Birmaher B et al. Corticotropin-releasing hormone challenge in prepubertal major depression. Biol Psychiatry 1996; 39(4): 267-77.
44. Costello EJ, Keeler GP, Angold A. Poverty, race/ethnicity, and psychiatric disorder: a study of rural children. Am J Public Health 2001; 91(9): 1494-8.
45. Boyd CP et al. Prevalence of anxiety and depression in Australian adolescents: comparisons with worldwide data. J Genet Psychol 2000; 161(4): 479-92.
46. Doi Y, Roberts RE, Takeuchi K, Suzuki S. Multiethnic comparison of adolescent major depression based on the DSM-IV criteria in a U.S.-Japan study. J Am Acad Child Adolesc Psychiatry 2001; 40(11): 1308-15.
47. Essau CA, Petermann U. Depression bei Kindern und Jugendlichen. Z Klin Psychol Psychopathol Psychother 1995; 43(1): 18-33.
48. Simon GE, Savarino J. Suicide attempts among patients starting depression treatment with medications or psychotherapy. Am J Psychiatry 2007; 164(7): 1029-34.
49. Brent DA et al. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry 2009; 166(4): 418-26.
50. Vitiello B et al. Suicidal events in the treatment for adolescents with depression study (TADS). J Clin Psychiatry 2009; 70(5): 741-7.
51. Vitiello B et al. Depressive symptoms and clinical status during the treatment of adolescent suicide attempters study. J Am Acad Child Adolesc Psychiatry 2009; 48: 987-94.
52. Posner K et al. Columbia suicide severity rating scale C-SSRS. In: Conte Center for the Neuroscience of Mental Disorders (CCNMD), New York State Psychiatric Institute 2007.
53. Bridge JA et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007; 297(15): 1683-96.
54. Allroggen M, Fegert JM. Narzisstische Störungen bei Jugendlichen und ihre Bedeutung bei der Einordnung von so genannten Trittbrettfahrern. Nervenheilkunde 2010; 29: 438-441.